Global Protein Powders Market to Reach $38.9 Billion by 2030
The global market for Protein Powders estimated at US$27.4 Billion in the year 2022, is projected to reach a revised size of US$38.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Animal-based, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$22.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Plant-based segment is readjusted to a revised 4.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $7.5 Billion, While China is Forecast to Grow at 8.7% CAGR
The Protein Powders market in the U.S. is estimated at US$7.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 3.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.Select Competitors (Total 12 Featured) -
- Abbott Laboratories
- ABH Pharma Inc.
- Amway
- Atlantic Multipower UK Limited
- Dalblads
- Garden of Life
- Glanbia Group
- GlaxoSmithKline
- GNC Holdings
- Herbalife International of America, Inc.
- Isostar
- Living Inc
- Makers Nutrition
- Melaleuca Inc
- Shaklee Corporation
- Suppleform
- USANA Health Sciences
- Vitaco Health
- Vitacost.com;
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ABH Pharma Inc.
- Amway
- Atlantic Multipower UK Limited
- Dalblads
- Garden of Life
- Glanbia Group
- GlaxoSmithKline
- GNC Holdings
- Herbalife International of America, Inc.
- Isostar
- Living Inc
- Makers Nutrition
- Melaleuca Inc
- Shaklee Corporation
- Suppleform
- USANA Health Sciences
- Vitaco Health
- Vitacost.com
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 78 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 27.4 Billion |
Forecasted Market Value ( USD | $ 38.9 Billion |
Compound Annual Growth Rate | 4.5% |
Regions Covered | Global |